CD274 and neoplasm: As this latter property of fibrocytes may be beneficial in tumor microenvironment (Henrot et al., 2021), especially when cancer patients were treated with anti–PD-1/PD-L1 antibody, it might be rather detrimental in COPD patients, by promoting tissue damages and chronic immune inflammation.